Hosted on MSN22h
Neurizon sets out to capture the market in neurodegenerative disease therapies
This is the goal which Neurizon Therapeutics Ltd – the company formerly known as PharmAust – is pursuing through development ...
Neurizon Therapeutics Receives Positive Opinion on Orphan Medicinal Product Designation for NUZ-001 in Europe
Neurizon Therapeutics Limited (ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing ...
NUZ inks positive opinion on orphan product designation for NUZ-001 in Europe
Neurizon has been buoyed by the receipt of a positive opinion from the European Medicines Agency in relation to its ...
manilatimes3d
ZTE unveils industry's first AI FWA Solution under its upgraded product philosophy GIS 2.0
ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of integrated information and communication technology solutions, has debuted the industry's first AI-powered full-stack FWA solution, ...
Hosted on MSN4d
Neurizon's fast-track application for flagship drug in Europe received 'positively'
While the final decision is set for next month, biotech player Neurizon’s (ASX:NUZ) hopes have been lifted with a view ...